Back to 
EARNEST PARTNERS LLC
EARNEST PARTNERS LLC
INO
Showing 0 of 20 quarters
Position history for EARNEST PARTNERS LLC's holdings in INOVIO PHARMACEUTICALS INC
No. Earnest Partners exited its INO (Inovio Pharmaceuticals) position in Q4 2023. Its Q3 2023 13F listed 2,750 shares worth $1,070. Earnest Partners already held INO in its Q1 2019 13F, the earliest on record, and held it in 19 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.